Pharmacokinetic-Pharmacodynamic Modeling of Stimulatory and Sedative Effects of Alprazolam: Timing Performance Deficits
- 1 December 1997
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 283 (3) , 1119-1129
- https://doi.org/10.1016/s0022-3565(24)37120-4
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokineticsPsychopharmacology, 1996
- Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokineticsPsychopharmacology, 1996
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivoPsychopharmacology, 1990
- Analysis of the role of behavioural factors in the development of tolerance to the benzodiazepine midazolamNeuropharmacology, 1987
- Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administrationPsychopharmacology, 1984
- Alprazolam: Pharmacokinetics, Clinical Efficacy, and Mechanism of ActionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- The effects of caffeine on timing behaviour in rodents: Comparisons with chlordiazepoxidePsychopharmacology, 1980
- Effects of repeated administration of chlordiazepoxide on spontaneous locomotor activity in micePsychopharmacology, 1979
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979